Paul L. Berns, President and CEO at Anacor Pharmaceuticals, Inc. (ANAC), sold 2,220 shares at $112.33 ($249K) on 2016-01-04, disclosed to the SEC on 2016-01-05.
Open-market sale of $249k ANAC by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NMRA | SELL | 2026-02-19 | $34K | — | Filing → |
| NMRA | SELL | 2025-02-20 | $23K | — | Filing → |
| MTSR | BUY | 2025-02-03 | $14.2M | — | Filing → |